Project description
Innovative tumour targeting tools for diagnosis and treatment
Proteases are often strongly overexpressed in the tumour microenvironment (TME), and their active sites allow high-affinity binding of vectors. That makes proteases ideal candidates for tumour targeting, and recent innovations involve small molecule vectors to target TME proteases. Funded by the Marie Skłodowska-Curie Actions programme, the OncoProTools project aims to make a breakthrough in cancer diagnosis and therapy by developing innovative approaches for protease targeting in chimeric antigen receptor T-cell therapy, discovering new vectors that bind more of the TME proteases, and introducing innovative diagnostics, based on a better understanding of TME biology. In addition, the OncoProTools will deliver training to 10 doctoral candidates, providing them with the capabilities to become leaders in cancer research.
Fields of science
Programme(s)
- HORIZON.1.2 - Marie Skłodowska-Curie Actions (MSCA) Main Programme
Funding Scheme
HORIZON-AG-UN - HORIZON Unit Grant
Coordinator
2000 Antwerpen
Belgium
See on map
Participants (7)
1165 Kobenhavn
See on map
01328 Dresden
See on map
55122 Mainz
See on map
1047 Budapest
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
28006 Madrid
See on map
1649-003 Lisboa
See on map
40125 Bologna
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
Partners (12)
2600 Berchem
See on map
3590 Diepenbeek
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
2650 Edegem
See on map
3012 Bern
See on map
1085 Budapest
See on map
28049 Madrid
See on map
40126 Bologna
See on map
01069 Dresden
See on map
10243 Berlin
See on map
1210 Bruxelles
See on map
3010 Bern
See on map